HIT Consultant June 24, 2021
Fred Pennic

What You Should Know:

Medable Inc., a software platform for patient-centered drug development, today announced an industry-first digital certification program that provides life sciences companies with specialized tools, knowledge sharing and skills development to rapidly scale their decentralized and hybrid trial strategies.

– Hybrid/decentralized clinical trials have unleashed an entirely new patient experience, but this new approach to clinical research will only work if the full ecosystem of partnering companies can work together seamlessly. There are CROs, virtual CROs, wearable device manufacturers, data companies, home-healthcare service companies, and many other organizations in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing

Share This Article